PUSHING THE LIMITS PODCAST

Well, hey everybody, and welcome to my YouTube channel. Today I'm going to be talking about the immune system as the master clock of aging, and how to measure and support it.

I want to start with a question that changed how I think about aging completely. How old is your immune system? Not how old you are — your immune system is different. Because here's what almost nobody understands: there are two numbers that are often wildly different. And it's your immune system's age, not the number on your birth certificate, that's quietly deciding how well you're going to live, how fast you recover from anything, and honestly, how long you've got on this beautiful planet of ours.

I came to this the hard way. Many of you know, if you follow my channel, that I've spent the last 10, 11, 12 years as the primary carer for my mum — through an aneurysm, a stroke, brain cancer, a stack of comorbidities. And when you live inside a medical crisis for years, you stop caring about theory and you start asking one question about everything: does this actually move the needle, and can I measure it?

That question led me down a rabbit hole into immunology and longevity science. And it led me to build a tool that I'm going to show you today, and to help formulate a product that I'm genuinely proud of. But first, I need to show you what's actually happening inside your immune system as the years tick over, because once you see it, you can't unsee it — and you'll want your number. So let's dive in.

Here's the thing about the immune system and aging: two things are happening at once, and they pull in completely opposite directions. Understand these two forces and everything else in this video will click into place.

The first is immunosenescence — which is a really big word that just means your immune system is getting weaker, slower, and less precise. And a huge chunk of this traces back to one tiny organ sitting just behind your breastbone, called the thymus. The thymus is the training academy for your T cells — putting it very simply, your adaptive immune soldiers, the ones that learn to recognize specific threats. And here's the brutal bit: the thymus starts shrinking from puberty. Yep, from puberty. So by the time you're middle-aged, it's largely turned to fat. So you're producing fewer and fewer naive T cells — the recruits that can recognize something they've never met before — and you're left leaning on your old memory cells over and over again. That's exactly why a brand-new virus, or a vaccine, hits a 70-year-old's immune system so differently to that of a 30-year-old's. There just aren't enough new soldiers left to send.

Now, the second force is the complete opposite problem. As the system loses its sharpness, it simultaneously gets noisier. This is called inflammaging — a chronic, low-grade background inflammation that never fully switches off. And this is the sneaky one, because you can't feel it. It's not like a swollen ankle when you sprain it. It's silent. It's a smoldering fire burning away in the background of your body, year after year. And it's one of the single strongest predictors we have of frailty, heart disease, dementia, cancer, and how long you're going to live.

A big driver is something called senescent cells, or in popular terms, zombie cells. They should have died and cleared out, but instead they sit there refusing to leave, pumping out inflammatory signals to everything around them — think of a grumpy old man spreading his doom and gloom. So add a lifetime of immune activation, a changing gut, and old viruses your body is still having to police in the background — which is also taking up a lot of your energy — and you get this constant inflammatory hum that slowly ages every system you've got.

So that's the picture: weaker where you need it, louder where you don't. Fewer sharp new soldiers, more background noise. And here's the punchline that took me years to really fully appreciate: almost every disease we associate with getting old sits somewhere on that exact spectrum. Which raises the obvious question — if this is happening silently, how on earth do I know where I stand, and can I actually do anything about it? For a long time, the honest answer was: you couldn't really measure it, and you couldn't really move it. And that has completely changed.

And to explain how, I have to introduce you to one of the most important conversations I've ever had on this podcast. I recently sat down with Dr David Furman — and if you care about aging, you need to know this man's work. He's absolutely amazing. Dr David Furman is the director of the 1,000 Immunomes Project at Stanford University and the Buck Institute. He's an associate professor at the Buck. The Buck Institute is basically the world's leading institute dedicated purely to the science of aging. And he's co-founded companies taking this research out into the world.

So back in 2007 — nearly two decades ago now — David and his team did something almost nobody was doing. Instead of studying mice, they went straight to humans. They took deep immune data from around a thousand people, aged 18 to over 100, and they followed some of them for 14 to 15 years. They measured everything — thousands of proteins, hundreds of different immune cell populations, gene expression — and then they used AI and machine learning to find the patterns hiding in that ocean of data. And here's what they kept finding, over and over, no matter what they looked at: aging signals. Signatures of aging written all over the immune system. It was so consistent that it redirected David's entire career. He came to believe — and he now has the data to back it — that you can use the human immune system to understand aging itself.

Out of that work came something they call iAge, which is an inflammatory aging clock. Now, you may have heard of other biological clocks, like the epigenetic clocks, the methylation clocks. David's is different, and this is why I love it. Instead of reading DNA methylation patterns — and I've done interviews with the leading people in this area, people like Ryan Smith at TruDiagnostic, which, as he freely admits, are still hard to interpret and act on — iAge, the one from the Buck Institute and the 1,000 Immunomes Project, Dr David's one, measures soluble proteins actually circulating in the blood. And that matters enormously, because a protein in your blood is something you can potentially change. You can find what raises it and what lowers it.

He gave me one example that sort of stopped me. There's a protein called CXCL9 — it's a chemokine. When it's elevated in your blood, it's associated with stiffening arteries and an enlarging, struggling heart. Real cardiovascular aging. And do you know one thing that drives CXCL9 up? Formaldehyde — which is off-gassing from new furniture, new carpets, sitting in the air of a freshly renovated room. That's how specific and how actionable this is getting.

This connects to the paper of David's that reframed everything for me. His work makes the case that chronic inflammation isn't just one of the hallmarks of aging — it sits underneath and drives almost all of them. But he's very particular about the language, and I want you to hear this because it's important. He doesn't even like the word "inflammation" for this, because you picture a swollen, red, hot ankle that just got sprained. When you hear that word — that's acute inflammation, a response to an injury or an infection. What we're talking about is completely different. He calls it sterile inflammation. Sterile, because there's no infection, there's no wound — and you're sort of fighting a ghost. So where does the ghost come from? It comes from the environment: the air pollution, the plastics and plasticizers in our food, the hyperglycemic, blood-sugar-spiking diets, the water quality, and — write this one down — a poor, low-diversity gut microbiome. He named that specifically as a driver of chronic inflammation. And hold that thought, because we're coming back to your gut in a big way.

Now here's the part that lit me up. This inflammatory clock isn't just a diagnosis. In a double-blind, placebo-controlled trial in around 200 people, published in the peer-reviewed literature, David's team